Muramyl Peptides as Possible Endogenous Immunopharmacological Mediators (Q40164050)

18 September 2017

1 reference

title

Muramyl peptides as possible endogenous immunopharmacological mediators (English)

1 reference

18 September 2017

Muramyl Peptides as Possible Endogenous Immunopharmacological Mediators (English)

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

7 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

7 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

7 October 2023

author name string

L. Chedid

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6358804

7 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6358804

7 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1348-0421.1983.tb00636.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6358804

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1348-0421.1983.tb00636.x

7 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1348-0421.1983.tb00636.x/fullpdf

7 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Microbiology and Immunology

7 October 2023

published in

1 reference

18 September 2017

27

1 reference

18 September 2017

723-732

1 reference

18 September 2017

9

1 reference

Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Immunological castration of male mice by a totally synthetic vaccine administered in saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Sleep-promoting effects of muramyl peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Synthetic immunostimulants derived from the bacterial cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Anti-influenza response achieved by immunization with a synthetic conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Central pyrogenic activity of muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Vaccination of Experimental Monkeys Against Plasmodium falciparum : A Possible Safe Adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1983.TB00636.X

Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity

7 October 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide

7 October 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species

7 October 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides

7 October 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides

7 October 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

The effect of some bacterial products on temperature and sleep in rat

7 October 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse

7 October 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Endotoxin-like properties of the peptidoglycan

7 October 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

7 October 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Stimulation of the reticuloendothelial system of mice by muramyl dipeptide

7 October 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs

7 October 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1348-0421.1983.TB00636.X

7 October 2023

Identifiers

1 reference

18 September 2017

1 reference